Department Of Chemistry

Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression. Read More

Dean of the College of Arts and Science Lauren Benton has announced the appointment of two senior faculty members as divisional deans in the college. The new positions will facilitate academic planning in departments and programs within the three Arts and Science divisions: humanities, social sciences and sciences. Read More

Vanderbilt investigators have developed a way to detect malaria that is faster and more sensitive than current clinical methods — a development that has the potential to make malaria detection significantly less expensive and more stable. Read More

Walter Chazin, Ph.D., director of the Vanderbilt Center for Structural Biology, is a recipient of a 2016 Fellow of the Biophysical Society award. Read More

New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs. Read More

La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders. Read More

Vanderbilt investigators have developed a framework for studying cellular responses that could be used to identify the agents driving a range of biological processes in health and disease. Read More

Vanderbilt researchers have discovered how certain molecules with antibiotic properties are synthesized, findings that could lead to new drugs that overcome the increased antibiotic resistance in bacteria. Read More

Richard N. Armstrong, Ph.D., professor of Biochemistry and Chemistry, prominent biochemist, journal editor and mentor, died on June 18 after a brief illness. He was 66. Read More

A new imaging probe developed by Vanderbilt investigators enhances tumor visibility and has broad applications in diagnosing and monitoring patients with cancer. Read More

Inhibitors of the enzyme phospholipase D1 suppress the replication of HIV-1, Vanderbilt investigators have discovered. Read More

Vanderbilt and the Waters Centers of Innovation Program are sponsoring a free symposium titled "Integrated 'Omics in Translational Medicine" on March 23. It is open to all scientists interested in the subject. Read More

Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way. Read More

Vanderbilt's John McLean has received Agilent Technology's Thought Leader Award in recognition of his contributions to ion mobility mass spectrometry. Read More

Insights into the workings of DNA damage response proteins such as SMARCAL1 could suggest new ways to improve genome integrity and prevent cancer. Read More

A compound identified at Vanderbilt has therapeutic potential in protecting the kidney filter barrier. Read More

Vanderbilt researchers have discovered small molecules that turn off cancerous Ras signals in a new way. Read More

Targeting the enzyme FosB could make antibiotic-resistant staph bacteria sensitive to the antibiotic fosfomycin. Read More

The antioxidant vitamin E prevented the buildup of toxic products in a model of a rare genetic disorder, suggesting new strategies for therapeutic development. Read More

Vanderbilt University may nominate one candidate for the Camille & Henry Dreyfus Foundation, Inc. Camille Dreyfus Teacher Scholar Awards Program Read More